The Istituto Mediterraneo per i Trapianti e Terapie ad Alta Specializzazione (ISMETT) is the first hospital in Italy designed exclusively for transplants and treatment of end-stage organ diseases. ISMETT was first established as an experimental management project in 1997 thanks to a partnership which involved the Region of Sicily, ARNAS Civico Hospital and UPMC (University of Pittsburgh Medical Center
ISMETT boosted the Sicilian economy by €132.5 million in expenditure in 2013, generated 1,793 jobs and provided a net benefit of more than €73 million by retaining patients who otherwise would have traveled outside of Sicily for care, according to a new study by the Battelle Memorial Institute. At the same time, the partnership with UPMC provided access to research, training and advanced health care management.
The experimental management cannot be modified without fully altering the nature and model of ISMETT. UPMC manages ISMETT based on criteria of financial and reporting transparency. ISMETT’s financial requirements should be seen in the light of its complexity and outcomes. Following the recently published articles we wish to express our position in order to provide correct information and safeguard UPMC, and the patients and staff of ISMETT.